Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0000313143-13-000100

President & CEO sold 13,000 shares at an average $41.87 ($544,342)

  • President & CEO acquired 13,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CONCANNON BRIAN · President & CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2013-07-01 Exercise or conversion : show line 1 in the form +3,000 $13.05 $39,158 118,798 D
2013-07-01 Sale : show line 2 in the form −3,000 $41.84 $125,522 115,798 D
2013-07-01 Exercise or conversion : show line 3 in the form +10,000 $11.32 $113,175 125,798 D
2013-07-01 Sale : show line 4 in the form −10,000 $41.88 $418,820 115,798 D
Open-market sales · 13,000 sh · avg $41.87 · $544,342

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-07-01 Exercise or conversion : show line 5 in the form Non-Qualified Stock Option (right to buy) −10,000 $11.32 2013-09-15 10,000 20,000 D
2013-07-01 Exercise or conversion : show line 6 in the form Non-Qualified Stock Option (right to buy) −3,000 $13.05 2014-05-05 3,000 21,000 D
Loading xslF345X03/edgardoc.xml…